£59.00

Progettazione di farmaci antitubercolari

Price data last checked 12 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£59 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 79 days · 79 data points (no recent data)

Historical
Generating forecast…
£59.00 £56.05 £57.23 £58.41 £59.59 £60.77 £61.95 27 June 2026 16 July 2026 05 August 2026 24 August 2026 13 September 2026

Price Distribution

Price distribution over 79 days • 1 price levels

Days at Price
79 days 0 20 40 59 79 £59 Days at Price

Price Analysis

Most common price: £59 (79 days, 100.0%)

Price range: £59 - £59

Price levels: 1 different prices over 79 days

Description

L'attenzione dell'industria farmaceutica si è spostata dal processo di scoperta dei farmaci per tentativi ed errori a una progettazione razionale dei farmaci basata sulla struttura. Un processo di progettazione di farmaci affidabile e di successo potrebbe ridurre i tempi e i costi di sviluppo di agenti farmacologici utili. Oggi, a livello globale, la tubercolosi (TB), l'AIDS e la malaria sono le malattie più minacciose che l'umanità conosca e gli attuali regimi di trattamento sono minati da scarsi effetti a lungo termine e costi elevati. L'efficacia dei trattamenti disponibili è ridotta soprattutto a causa dell'emergere di ceppi microbici resistenti ai farmaci, che richiedono lo sviluppo di nuovi e migliori farmaci. Il presente libro descrive i tentativi compiuti per individuare le proteine bersaglio chiave necessarie per il funzionamento della via del peptidoglicano del Mycobacterium tuberculosis, per prevedere la struttura tridimensionale delle proteine bersaglio identificate e per progettare infine inibitori ad ampio spettro e con un buon potenziale come farmaci antitubercolari al fine di combattere la devastante malattia della tubercolosi.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 February 2024
Listed Since
27 February 2024

Barcode

No barcode data available

Similar Products You Might Like

Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions
80% match

Mycobacterium Tuberculosis: Molecular Infection Biology, Pathogenesis, Diagnostics and New Interventions

Springer

£107.47 14 Sep 2026
80% match

Structural and Functional Dynamics of Nontuberculous Mycobacterium Proteins: Insights into Pathogenic Mechanisms

Elsevier

£145.99 05 Aug 2026
Antituberculosis Drugs: 84 (Handbook of Experimental Pharmacology, 84)
79% match

Antituberculosis Drugs: 84 (Handbook of Experimental Pharmacology, 84)

Springer

£77.49 29 Aug 2026
Tuberculosis Host-Pathogen Interactions
79% match

Tuberculosis Host-Pathogen Interactions

Springer

£106.78 31 Aug 2026
Tuberculosis Host-Pathogen Interactions
78% match

Tuberculosis Host-Pathogen Interactions

Springer

£107.03 08 Sep 2026
Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs
78% match

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs

Springer

£108.01 08 Aug 2026
Mycobacterium Tuberculosis Protocols: 54 (Methods in Molecular Medicine, 54)
78% match

Mycobacterium Tuberculosis Protocols: 54 (Methods in Molecular Medicine, 54)

Humana

£80.67 06 Aug 2026
Peptide and Protein Design for Biopharmaceutical Applications
78% match

Peptide and Protein Design for Biopharmaceutical Applications

Wiley

£97.01 08 Aug 2026
Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)
77% match

Tuberculosis: 215 (Current Topics in Microbiology and Immunology, 215)

Springer

£76.42 08 Aug 2026
Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)
77% match

Antiviral Drugs - The Rational Design of Antiviral Agents: The Most Updated Crash Course from Beginner to Advanced Learn All the Functions and ... in 7 Days or Less (Pharmaceutical Science)

£114.00 14 Sep 2026
Drug Discovery and Design (Volume 56) (Advances in Protein Chemistry, Volume 56)
76% match

Drug Discovery and Design (Volume 56) (Advances in Protein Chemistry, Volume 56)

Elsevier

£40.04 14 Sep 2026
Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)
76% match

Rational Design of Stable Protein Formulations: Theory and Practice: 13 (Pharmaceutical Biotechnology, 13)

Springer

£108.01 07 Aug 2026
Protein Design: 340 (Methods in Molecular Biology, 340)
76% match

Protein Design: 340 (Methods in Molecular Biology, 340)

Humana

£108.01 06 Aug 2026
Mycobacteria: Molecular Biology and Virulence
75% match

Mycobacteria: Molecular Biology and Virulence

Wiley

£239.47 08 Aug 2026
Tuberculosis and Nontuberculosis Mycobacterial Infections
75% match

Tuberculosis and Nontuberculosis Mycobacterial Infections

McGraw-Hill Education

£63.99 06 Aug 2026
Antibiotics: A Multidisciplinary Approach
75% match

Antibiotics: A Multidisciplinary Approach

Springer

£113.93 06 Aug 2026
New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis
75% match

New therapeutic compounds against tuberculosis: In silico design of new therapeutic compounds targeting biosynthetic pathway of Mycolic acid in M. tuberculosis

LAP Lambert Academic Publishing

£68.00 21 Aug 2026
Biopharmaceutical Drug Design and Development
75% match

Biopharmaceutical Drug Design and Development

Humana

£109.14 04 Aug 2026
Molecular Targets and Therapeutic Design: Volume 153 (Advances in Protein Chemistry and Structural Biology, Volume 153)
75% match

Molecular Targets and Therapeutic Design: Volume 153 (Advances in Protein Chemistry and Structural Biology, Volume 153)

Elsevier

£119.00 06 Aug 2026
Patenting of Pharmaceuticals and Development in Sub-Saharan Africa: Laws, Institutions, Practices, and Politics
75% match

Patenting of Pharmaceuticals and Development in Sub-Saharan Africa: Laws, Institutions, Practices, and Politics

Springer

£76.42 08 Aug 2026
The New Paradigm of Immunity to Tuberculosis: 783 (Advances in Experimental Medicine and Biology, 783)
75% match

The New Paradigm of Immunity to Tuberculosis: 783 (Advances in Experimental Medicine and Biology, 783)

Springer

£107.42 04 Aug 2026
Disruption of Protein-Protein Interfaces: In Search of New Inhibitors
75% match

Disruption of Protein-Protein Interfaces: In Search of New Inhibitors

Springer

£76.42 06 Aug 2026
Diseño de fármacos asistido por ordenador: Desarrollo de nuevas moléculas heterocíclicas
75% match

Diseño de fármacos asistido por ordenador: Desarrollo de nuevas moléculas heterocíclicas

£68.00 13 Aug 2026
Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria
75% match

Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria

Springer

£108.01 07 Aug 2026